Geistlich - Indication sheets PIR2 - Periimplant Regeneration

Periimplant Regeneration Literature references  Benic GI, Jung RE, Siegenthaler DW, Hämmerle CHF. Clinical and radiographic comparison of implants in regenerated or native bone: 5-year results. Clin Oral Implants Res 2009; 20: 507-513. 1 Jung RE, Fenner N, Hammerle CHF, Zitzmann NU. Long-term outcome of impants placed with guided bone regeneration (GBR) using resorbable and non-resorbable membranes after 12-14 years. Clin Oral Implants Res 2012: 1-9. 2 Tal H et al., Long-term bio-degradation of cross-linked and non-cross-linked collagen barriers in human guided bone regeneration. Clin Oral Implants Res 2008;19:295-302 3 Becker J et al., Use of a new cross-linked collagen membrane for the treatment of dehiscence-tpye defects at titanium implants: a prospective, randomized-controlled double-blinded clinical multicenter study. Clin Oral Implants Res 2009;20:742-749 4 Suppliers > Anti-inflammatory medication: 500 mg Méfénacid, Streuli Pharma AG, Switzerland > Anti-septic medication: 750 mg Amoxicillin, Streuli Pharma AG, Switzerland, Chlorhexidin 0.2% Kantonsapotheke Zürich, Switzerland > Suture material (ePTFE): GORE-TEX® CV-5 Suture, W.L. Gore & Associates, Inc., USA > Implant system: Straumann® Bone Level Implant System, Institut Straumann AG, Switzerland > Biomaterials: Geistlich Bio-Gide® 25x25 mm, 2 Geistlich Bio-Oss® Collagen 100 mg, Geistlich Pharma AG, Switzerland Contact Dr. Christian Ramel, Clinic of Fixed and Removable Prosthodontics, Universitiy of Zurich, and Private Practice, Zurich, Switzerland >  ingle Implant placement with concomitant ridge augmentation with Geistlich S Bio-Gide® and Geistlich Bio-Oss® Collagen for a double-tooth gap in the lower front region > Dr. Christian Ramel, Plattenstrasse 11, CH-8032 Zürich, Switzerland phone: [phone], fax: [phone], e-mail: [email protected], www.zzm.uzh.ch Further Indication Sheets >  free delivery please contact: www.geistlich.com/indicationsheets For >  you no longer wish to collect Indication Sheets, please unsubscribe with your local distribution partner If 1. Indication profile Region n bone defect present n no bone defect present n recession n no recession n infected n thick biotype n thin biotype n primary wound closure possible n primary wound closure not possible n intact papillae n impaired, missing papillae n adequate keratinised mucosa Implantation n non-aesthetic region n multiple tooth gap n inflamed Bony situation Soft tissue situation n aesthetic region n single tooth gap n inadequate keratinised mucosa n uneventful n simultaneously with bone augmentation (1 step) n successively to bone augmentation (2 steps) Geistlich Pharma AG Business Unit Biomaterials CH-6110 Wolhusen phone [phone] fax [phone] www.geistlich-pharma.com © 1 4 31593.1/1301/e Indication Sheet PIR-2